100.72
前日終値:
$100.57
開ける:
$100.41
24時間の取引高:
7.27M
Relative Volume:
0.86
時価総額:
$149.24B
収益:
$19.35B
当期純損益:
$2.78B
株価収益率:
53.87
EPS:
1.8696
ネットキャッシュフロー:
$3.49B
1週間 パフォーマンス:
-0.39%
1か月 パフォーマンス:
+3.17%
6か月 パフォーマンス:
-2.09%
1年 パフォーマンス:
+19.88%
Boston Scientific Corp Stock (BSX) Company Profile
名前
Boston Scientific Corp
セクター
電話
508-683-4000
住所
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
BSX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.69B | 1.41B | 577.90M | 1.8485 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-03 | ダウングレード | Erste Group | Buy → Hold |
| 2025-09-08 | アップグレード | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 開始されました | Leerink Partners | Outperform |
| 2025-04-16 | アップグレード | Needham | Hold → Buy |
| 2025-01-10 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-10-18 | ダウングレード | Needham | Buy → Hold |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2024-02-01 | アップグレード | Mizuho | Neutral → Buy |
| 2023-07-19 | 開始されました | Robert W. Baird | Outperform |
| 2023-06-30 | 開始されました | CL King | Buy |
| 2023-05-30 | 再開されました | Morgan Stanley | Overweight |
| 2023-03-29 | 開始されました | UBS | Buy |
| 2022-12-22 | 開始されました | Mizuho | Neutral |
| 2022-12-20 | 再開されました | Citigroup | Buy |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-06 | 開始されました | Wolfe Research | Outperform |
| 2022-05-27 | アップグレード | Needham | Hold → Buy |
| 2022-04-13 | 再開されました | Truist | Buy |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-05-26 | ダウングレード | Needham | Buy → Hold |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-17 | 開始されました | Truist | Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Peer Perform |
| 2020-04-22 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | アップグレード | Goldman | Neutral → Buy |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Neutral |
| 2020-02-06 | 再開されました | BTIG Research | Buy |
| 2019-12-30 | 繰り返されました | Cowen | Outperform |
| 2019-12-19 | ダウングレード | Needham | Strong Buy → Buy |
| 2019-09-05 | 再開されました | JP Morgan | Overweight |
| 2019-09-03 | 再開されました | Barclays | Overweight |
| 2019-05-13 | アップグレード | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 開始されました | UBS | Buy |
| 2018-10-16 | 開始されました | Barclays | Overweight |
| 2018-10-02 | 繰り返されました | Morgan Stanley | Overweight |
| 2018-09-07 | 繰り返されました | Needham | Strong Buy |
| 2018-09-04 | アップグレード | Jefferies | Hold → Buy |
| 2018-07-06 | 繰り返されました | Needham | Strong Buy |
| 2018-06-27 | 開始されました | Bernstein | Outperform |
| 2018-04-26 | 繰り返されました | Needham | Strong Buy |
すべてを表示
Boston Scientific Corp (BSX) 最新ニュース
Can Boston Scientific Corporation stock test all time highs2025 Risk Factors & Long-Term Growth Portfolio Plans - newser.com
What market sentiment indicators show for Boston Scientific Corporation stockM&A Rumor & Safe Entry Zone Identification - newser.com
Is Boston Scientific Corporation stock a smart buy before Fed meetingQuarterly Performance Summary & Expert Curated Trade Ideas - newser.com
Lockheed Martin Investment Management Co. Lowers Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Is Boston Scientific (BSX) Becoming the Leading MedTech Growth Story? - Insider Monkey
Do Wall Street Analysts Like Boston Scientific Stock? - Barchart.com
Heritage Investors Management Corp Decreases Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
How Boston Scientific Corporation stock moves in volatile trading sessions2025 Trade Ideas & Consistent Growth Equity Picks - newser.com
Global Cardiac Monitoring Devices Market to Cross USD 30 Billion by 2032, Driven by Telehealth and Remote Monitoring Trends | DelveInsight - GlobeNewswire Inc.
Buy Boston Scientific Stock. It’s a Way to Diversify From AI? - Barron's
Looking to Diversify Away From AI? Buy Boston Scientific Stock. - Barron's
Risk vs reward if holding onto Boston Scientific CorporationTrade Risk Assessment & Daily Volume Surge Trade Alerts - newser.com
Chart based analysis of Boston Scientific Corporation trends2025 Price Action Summary & Weekly High Return Forecasts - newser.com
Canaccord Genuity Reiterates a Buy on Boston Scientific Corporation (BSX) - Insider Monkey
Technical signs of recovery in Boston Scientific CorporationTrend Reversal & Low Volatility Stock Recommendations - newser.com
Can Boston Scientific Corporation stock sustain revenue momentumTrade Analysis Summary & Low Risk Entry Point Tips - newser.com
OVERSEA CHINESE BANKING Corp Ltd Has $259,000 Holdings in Boston Scientific Corporation $BSX - MarketBeat
5 Insightful Analyst Questions From Boston Scientific’s Q3 Earnings Call - Yahoo Finance
Ellen Zane Sells Shares of Boston Scientific Corp - GuruFocus
Private Wealth Partners LLC Sells 18,631 Shares of Boston Scientific Corporation $BSX - MarketBeat
Will Boston Scientific Corporation stock outperform Nasdaq indexWeekly Investment Summary & Growth Focused Entry Point Reports - fcp.pa.gov.br
BSX Stock Quote Price and Forecast - CNN
Will Boston Scientific Corporation stock gain from strong economyAnalyst Downgrade & Low Risk Profit Maximizing Plans - newser.com
How Boston Scientific Corporation stock performs after earningsJuly 2025 PreEarnings & Smart Money Movement Alerts - fcp.pa.gov.br
Is Boston Scientific Corporation stock ready for a breakoutShort Setup & Daily Technical Forecast Reports - newser.com
EPS Watch: Will Boston Scientific Corporation stock justify high valuationJuly 2025 Earnings & AI Enhanced Trading Alerts - fcp.pa.gov.br
Boston Scientific’s Innovative Approach to Gastric Outlet Obstruction: Study Update - TipRanks
Boston Scientific’s SIMPLAAFY Trial: A New Frontier in Atrial Fibrillation Treatment - TipRanks
Boston Scientific’s Orbera365™ Study: A New Frontier in Weight Loss Management - TipRanks
Boston Scientific’s New Study on Pacemaker Leads: What Investors Need to Know - TipRanks
Boston Scientific’s RHAPSODY Study: A Step Forward in Cardiac Care Innovation - TipRanks
Boston Scientific’s Hot AXIOS™ Stent Study: A Potential Game-Changer in Bile Duct Drainage - TipRanks
Boston Scientific’s Innovative Approach to Atrial Fibrillation: A Study Update - TipRanks
Boston Scientific’s Vercise™ DBS Study: A Real-World Evaluation of Dystonia Treatment - TipRanks
Boston Scientific shares positive Agent drug-coated balloon findings - MassDevice
Does Boston Scientific (BSX) Have the Potential to Rally 25.61% as Wall Street Analysts Expect? - Yahoo Finance
Schmidt P J Investment Management Inc. Boosts Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Is Boston Scientific Corporation stock a buy in volatile marketsWeekly Trend Recap & Accurate Technical Buy Alerts - newser.com
Boston Scientific Hits Day High with 3.95% Surge, Outperforming S&P 500 - Markets Mojo
Comparing Boston Scientific Corporation in custom built stock radarsMarket Growth Summary & Real-Time Chart Breakout Alerts - newser.com
Evaluating Boston Scientific Corporation with trendline analysisJuly 2025 Selloffs & Precise Swing Trade Alerts - newser.com
Boston Scientific (NYSE:BSX) Earns Buy (B-) Rating from Weiss Ratings - MarketBeat
Boston Scientific Corp (BSX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):